XJPX
3001
Market cap505mUSD
Jul 10, Last price
2,584.00JPY
1D
-1.30%
1Q
-6.04%
Jan 2017
89.03%
Name
Katakura Industries Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Katakura Industries Co.,Ltd. is a diversified Japanese enterprise, active across multiple sectors including textiles, pharmaceuticals, machinery, real estate, and various life solutions. Its textile division manufactures and sells a broad range of products, from undergarments, hosiery, and aprons to comfort apparel, alongside specialized functional fibers such as the water-soluble Solvron and the heat-resistant NITIVY ALF. In the pharmaceutical realm, Katakura develops and supplies medications for cardiovascular conditions, notably Frandol for angina pectoris, and the cardiac drug Frandol Tape. The company's machinery operations cover the production and distribution of environmental equipment (including washers), cutting oil products, fire engines and related firefighting apparatus, agricultural machinery, and automotive components. For real estate, services include commercial property management, land leasing, and development initiatives. Furthermore, its life solutions portfolio encompasses agricultural products, foodstuffs, nursing care equipment, comprehensive building maintenance, landscaping services, and the operation of specialty stores for plants and pets. The company, which now has its headquarters in Tokyo, Japan, was established in 1873 as Katakura Silk Spinning Co., Ltd., adopting its present name, Katakura Industries Co.,Ltd., in November 1943.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||